Response to the AAP section on urology concerns about the AAP urinary tract infection guideline

Pediatrics

Volumn 129, Issue 4, 2012, Pages

  Roberts, Kenneth B ^a   Finnell, S Maria E ^b   Downs, Stephen M ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; CHILD; FALSE POSITIVE RESULT; FEVER; HUMAN; KIDNEY FUNCTION; MICTURITION; MICTURITION CYSTOURETHROGRAPHY; MICTURITION REFLEX; NOTE; PEDIATRICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RISK ASSESSMENT; URINARY TRACT INFECTION; URINE CULTURE; UROLOGY;

EID: 84859412978     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-3860     Document Type: Note

References (12)

1. Wan J, Skoog SJ, Hulbert WC, et al. Section on Urology Response to the New Guidelines for the Diagnosis and Management of UTI. Pediatrics. 2012;129(4). Available at: www.pediatrics.org/cgi/content/full/129/4/e1051
2. American Academy of Pediatrics Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management. Urinary tract infection: Clinical Practice Guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics. 2011;128(3):595-610
3. Garin EH, Olavarria F, Garcia Nieto V, Valenciano B, Campos A, Young L. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics. 2006;117(3):626-632 (Pubitemid 46063202)
4. Montini G, Rigon L, Zucchetta P, et al IRIS Group. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics. 2008;122(5):1064-1071
5. Roussey-Kesler G, Gadjos V, Idres N, et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. J Urol. 2008;179(2):674-679
6. Pennesi M, Travan L, Peratoner L, et al; North East Italy Prophylaxis in VUR study group. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics. 2008;121(6). Available at: www.pediatrics.org/cgi/ content/full/121/6/e1489
7. Craig JC, Simpson JM, Williams GJ, et al Prevention of Recurrent Urinary Tract Infection in Children with Vesicoureteric Reflux and Normal Renal Tracts (PRIVENT) Investigators. Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med. 2009;361(18):1748-1759
8. Brandström P, Esbjörner E, Herthelius M, Swerkersson S, Jodal U, Hansson S. The Swedish reflux trial in children: III. Urinary tract infection pattern. J Urol. 2010;184(1):286-291
9. Finnell SM, Carroll AE, Downs SM; Subcommittee on Urinary Tract Infection. Tehnical Report - Diagnosis and management of an initial UTI in febrile infants and young children. Pediatrics. 2011;128(3). Available at: www.pediatrics.org/cgi/content/full/129/3/e749
10. The Cochrane Collaboration. Cochrane Collaboration open learning material for reviewers. Available at: www.cochrane-net.org/openlearning/PDF/ Openlearning-full. pdf. Accessed December 19, 2011
11. Schroeder AR, Abidari JM, Kirpekar R, et al. Impact of a more restrictive approach to urinary tract imaging after febrile urinary tract infection. Arch Pediatr Adolesc Med. 2011;165(11):1027-1032
12. Salo J, Ikäheimo R, Tapiainen T, Uhari M. Childhood urinary tract infections as a cause of chronic kidney disease. Pediatrics. 2011;128(5):840-847